GSW, powered by Syneos Health, led the global launch of CAMZYOS—a breakthrough cardiac myosin inhibitor and the first and only FDA-approved treatment of its kind for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). This multifaceted campaign included the development of a cohesive brand identity, commercial content, digital + physical marketing materials, and merchandise. From creative concepting to production, the work aimed to resonate across audiences—from cardiologists, HCPs, nurses, to patients—by simplifying complex science into engaging, digestible content.

Website Link

Value Added

• Led daily hot sheet meetings to align team on priorities and blockers
• Managed Medical, Legal, Regulatory (MLR) process and routing across all key departments: Account, Art, Copy, Editorial, Tech, Strategy, Medical
• Maintained and monitored multiple budgets, reallocating inactive line items to ensure maximum spend efficiency
• Oversaw proofing process for all physical and digital assets, ensuring approvals before deployment
• Conducted Quality Assurance (QA) and Quality Control (QC) for digital assets across desktop and mobile to ensure brand consistency and functionality

Results

• Elevated brand awareness for CAMZYOS in the cardiology space
• Empowered patients with personalized information, science-backed research, and advocate-driven content
• Produced branded and unbranded videos, stories, and campaigns that engaged HCPs at a meaningful level
• Successfully translated complex medical science into compelling narratives and value propositions for multiple audiences